Targeted disruption of Gal-12 gene (Lgals12) in mice increased insulin sensitivity and glucose tolerance and contributed to diabetes and metabolic syndrome [4, 97], suggesting the potential role of this lectin in cardiovascular diseases. The gene discussed is LGALS12; the disease is metabolic syndrome.